STAT News

STAT+: Dutch antitrust regulators probe Biogen over test for its MS drug

Dutch antitrust regulators are investigating allegations that Biogen may have abused its dominant position in the market for MS treatments and associated blood tests.

By STAT News

1 min read
STAT+: Dutch antitrust regulators probe Biogen over test for its MS drug
AI-generated illustration

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights